The Wall Street Journal checks in with the "revolutionary" Glowing Plant
The progress of Glowing Plant, one of Genome Compiler’s flagship synbio partners and personal undertaking of Genome Compiler CEO Omri Amriav-Dory (as strategic adviser), has once again piqued the interest of the Wall Street Journal. In a series of recent blog articles and online videos, Wall Street Journal’s Deborah Kan has interviewed Glowing Plant’s CEO…
